{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:16:44Z","timestamp":1793740604392,"version":"4.6.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s13300-025-01812-w","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T08:43:07Z","timestamp":1761986587000},"page":"2275-2291","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Identifying the Healthcare Burden of Diabetic Ketoacidosis: Economic Analysis and Mitigation Strategies for Adult Patients in the United Arab Emirates"],"prefix":"10.1007","volume":"16","author":[{"given":"Fayez","family":"AlShamsi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketan K.","family":"Dhatariya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meira Sulaiman","family":"Aldhanhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naser Salem","family":"Alshkeili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Hareb M.","family":"Alsaadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashid Hamad","family":"Almansoori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2704-8931","authenticated-orcid":false,"given":"Adnan","family":"Agha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,1]]},"reference":[{"issue":"7","key":"1812_CR1","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.2337\/dc09-9032","volume":"32","author":"AE Kitabchi","year":"2009","unstructured":"Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32(7):1335\u201343.","journal-title":"Diabetes Care"},{"issue":"15","key":"1812_CR2","first-page":"471","volume":"69","author":"SR Benoit","year":"2020","unstructured":"Benoit SR, Zhang Y, Geiss LS, Gregg EW, Albright A. Trends in diabetic ketoacidosis hospitalizations and in-hospital mortality - United States, 2009\u20132017. MMWR Morb Mortal Wkly Rep. 2020;69(15):471\u20137.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8","key":"1812_CR3","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2337\/dc17-1379","volume":"41","author":"D Desai","year":"2018","unstructured":"Desai D, Mehta D, Mathias P, Menon G, Schubart UK. Health care utilization and burden of diabetic ketoacidosis in the U.S. over the past decade: a nationwide analysis. Diabetes Care. 2018;41(8):1631\u20138.","journal-title":"Diabetes Care"},{"issue":"1","key":"1812_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0165-1","volume":"6","author":"KK Dhatariya","year":"2020","unstructured":"Dhatariya KK, Glaser NS, Codner E, Umpierrez GE. Diabetic ketoacidosis. Nat Rev Dis Primers. 2020;6(1):40.","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"1812_CR5","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1111\/dme.13427","volume":"34","author":"K Dhatariya","year":"2017","unstructured":"Dhatariya K, Skedgel C, Fordham R. The cost of treating diabetic ketoacidosis in the UK: a national survey of hospital resource use. Diabet Med. 2017;34(10):1361\u20136.","journal-title":"Diabet Med"},{"issue":"2","key":"1812_CR6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/archdischild-2020-321397","volume":"107","author":"K Lokulo-Sodipe","year":"2022","unstructured":"Lokulo-Sodipe K, Moon RJ, Edge JA, Davies JH. Identifying targets to improve treatment and care in children and young people with diabetic ketoacidosis: analysis of UK national data. Arch Dis Child. 2022;107(2):181\u20137.","journal-title":"Arch Dis Child"},{"key":"1812_CR7","first-page":"8061547","volume":"2023","author":"MA Alazami","year":"2023","unstructured":"Alazami MA, Alotaibi AN, Almusawi AM, et al. Diabetic ketoacidosis in type\u00a02 diabetes mellitus: a cross-sectional study. J Diabetes Res. 2023;2023:8061547.","journal-title":"J Diabetes Res"},{"key":"1812_CR8","first-page":"42","volume":"143","author":"B Zabeen","year":"2018","unstructured":"Zabeen B, Nahar J, Tayyeb S, Nahar N, Azad K. DKA in children and adolescents with type\u00a01 diabetes in a tertiary hospital in Bangladesh. Diabetes Res Clin Pract. 2018;143:42\u20139.","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"1812_CR9","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.dsx.2012.02.020","volume":"5","author":"K Al-Rubeaan","year":"2011","unstructured":"Al-Rubeaan K, Aftab SA, Alotaibi MS, Alghamdi AA, Rafiullah MR. Clinico-laboratory characteristics and precipitating factors of diabetic ketoacidosis among type\u00a01 and type\u00a02 diabetic patients. Diabetes Metab Syndr. 2011;5(4):196\u2013200.","journal-title":"Diabetes Metab Syndr"},{"issue":"1","key":"1812_CR10","doi-asserted-by":"publisher","first-page":"17437","DOI":"10.1038\/s41598-019-53505-7","volume":"9","author":"R Hamoudi","year":"2019","unstructured":"Hamoudi R, Saheb Sharif-Askari N, Saheb Sharif-Askari F, et al. Prediabetes and diabetes prevalence and risk factors comparison between ethnic groups in the United Arab Emirates. Sci Rep. 2019;9(1):17437.","journal-title":"Sci Rep"},{"issue":"2","key":"1812_CR11","first-page":"244","volume":"65","author":"M Al-Maatouq","year":"2011","unstructured":"Al-Maatouq M, Al-Arouj M, Amod A, et al. Optimising the medical management of hyperglycaemia in type\u00a02 diabetes in the Middle East: pivotal role of metformin. Int J Clin Pract. 2011;65(2):244\u201352.","journal-title":"Int J Clin Pract"},{"issue":"3","key":"1812_CR12","doi-asserted-by":"publisher","first-page":"292","DOI":"10.26719\/2010.16.3.292","volume":"16","author":"RR Elmehdawi","year":"2010","unstructured":"Elmehdawi RR, Elmagerhei HM. Profile of diabetic ketoacidosis at a teaching hospital in Benghazi, Libyan Arab Jamahiriya. East Mediterr Health J. 2010;16(3):292\u20135.","journal-title":"East Mediterr Health J"},{"issue":"1","key":"1812_CR13","first-page":"32","volume":"37","author":"K Al-Rubeaan","year":"2017","unstructured":"Al-Rubeaan K, Youssef AM, Ibrahim HM, et al. Diabetic ketoacidosis in Saudi Arabia: clinical characteristics and precipitating factors in a tertiary center. Ann Saudi Med. 2017;37(1):32\u20137.","journal-title":"Ann Saudi Med"},{"issue":"9","key":"1812_CR14","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s13300-022-01298-w","volume":"13","author":"K Al Zahmi","year":"2022","unstructured":"Al Zahmi K, Al Dhaheri A, Al Shamsi F, et al. Clinical characteristics and outcomes of adult patients with diabetic ketoacidosis: a retrospective study from a tertiary care center in the United Arab Emirates. Diabetes Ther. 2022;13(9):1635\u201347.","journal-title":"Diabetes Ther"},{"issue":"4","key":"1812_CR15","first-page":"245","volume":"25","author":"C Mohler","year":"2023","unstructured":"Mohler C, Verma A, Williams K, et al. Impact of a comprehensive diabetes technology management program on diabetic ketoacidosis admissions and healthcare costs. Diabetes Technol Ther. 2023;25(4):245\u201353.","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"1812_CR16","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00125-020-05331-0","volume":"64","author":"K Kristensen","year":"2021","unstructured":"Kristensen K, Ogrin R, Semark B, et al. Continuous glucose monitoring in adults with type\u00a01 diabetes with structured education: a randomised controlled trial. Diabetologia. 2021;64(3):561\u201370.","journal-title":"Diabetologia"},{"issue":"24","key":"1812_CR17","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1056\/NEJMoa1716816","volume":"378","author":"N Kuppermann","year":"2018","unstructured":"Kuppermann N, Ghetti S, Schunk JE, et al. Clinical trial of fluid infusion rates for pediatric diabetic ketoacidosis. N Engl J Med. 2018;378(24):2275\u201387.","journal-title":"N Engl J Med"},{"issue":"12","key":"1812_CR18","doi-asserted-by":"publisher","first-page":"e196","DOI":"10.2337\/dc20-1258","volume":"43","author":"K Ramphul","year":"2020","unstructured":"Ramphul K, Joynauth J. An update on the incidence and burden of diabetic ketoacidosis in the United States. Diabetes Care. 2020;43(12):e196\u20137.","journal-title":"Diabetes Care"},{"issue":"5","key":"1812_CR19","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.1851","volume":"1","author":"AR Kahkoska","year":"2018","unstructured":"Kahkoska AR, Shay CM, Crandell J, et al. Association of race and ethnicity with glycemic control and hemoglobin A1c levels in youth with type\u00a01 diabetes. JAMA Netw Open. 2018;1(5):e181851.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"1812_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/dc23-ti01","volume":"46","author":"American Diabetes Association","year":"2023","unstructured":"American Diabetes Association. Economic costs of diabetes in the U.S. in 2022. Diabetes Care. 2023;46(1):1\u201310.","journal-title":"Diabetes Care"},{"issue":"1","key":"1812_CR21","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1001\/jamainternmed.2018.5008","volume":"179","author":"D Herkert","year":"2019","unstructured":"Herkert D, Vijayakumar P, Luo J, et al. Cost-related insulin underuse among patients with diabetes. JAMA Intern Med. 2019;179(1):112\u20134.","journal-title":"JAMA Intern Med"},{"issue":"9","key":"1812_CR22","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.2337\/dc15-0843","volume":"38","author":"AL Peters","year":"2015","unstructured":"Peters AL, Buschur EO, Buse JB, Cohan P, Diner JC, Hirsch IB. Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter\u00a02 inhibition. Diabetes Care. 2015;38(9):1687\u201393.","journal-title":"Diabetes Care"},{"issue":"6","key":"1812_CR23","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/pedi.12030","volume":"14","author":"E Cengiz","year":"2013","unstructured":"Cengiz E, Xing D, Wong JC, et al. Severe hypoglycemia and diabetic ketoacidosis among youth with type\u00a01 diabetes in the T1D Exchange clinic registry. Pediatr Diabetes. 2013;14(6):447\u201354.","journal-title":"Pediatr Diabetes"},{"key":"1812_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1475-2840-6-24","volume":"6","author":"F Al-Maskari","year":"2007","unstructured":"Al-Maskari F, El-Sadig M, Norman JN. The prevalence of macrovascular complications among diabetic patients in the United Arab Emirates. Cardiovasc Diabetol. 2007;6:24.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"1812_CR25","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S2213-8587(15)00521-5","volume":"4","author":"D Beran","year":"2016","unstructured":"Beran D, Ewen M, Laing R. Constraints and challenges in access to insulin: a global perspective. Lancet Diabetes Endocrinol. 2016;4(3):275\u201385.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1812_CR26","volume-title":"Global report on diabetes","author":"World Health Organization","year":"2023","unstructured":"World Health Organization. Global report on diabetes. Geneva: World Health Organization; 2023."},{"issue":"8","key":"1812_CR27","first-page":"825","volume":"121","author":"E Koornneef","year":"2017","unstructured":"Koornneef E, Robben P, Al Seiari M, Al Siksek Z. Health system reform in the Emirate of Abu Dhabi, United Arab Emirates. Health Policy. 2017;121(8):825\u201332.","journal-title":"Health Policy"},{"key":"1812_CR28","volume-title":"International statistical classification of diseases and related health problems 10th revision","author":"World Health Organization","year":"2019","unstructured":"World Health Organization. International statistical classification of diseases and related health problems 10th revision. Geneva: WHO; 2019."},{"issue":"5","key":"1812_CR29","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/j.1464-5491.2011.03246.x","volume":"28","author":"MW Savage","year":"2011","unstructured":"Savage MW, Dhatariya KK, Kilvert A, et al. Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis. Diabet Med. 2011;28(5):508\u201315.","journal-title":"Diabet Med"},{"issue":"4","key":"1812_CR30","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nrendo.2016.15","volume":"12","author":"G Umpierrez","year":"2016","unstructured":"Umpierrez G, Korytkowski M. Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev Endocrinol. 2016;12(4):222\u201332.","journal-title":"Nat Rev Endocrinol"},{"key":"1812_CR31","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3389\/fendo.2017.00106","volume":"8","author":"TTT Tran","year":"2017","unstructured":"Tran TTT, Pease A, Wood AJ, et al. Review of evidence for adult diabetic ketoacidosis management protocols. Front Endocrinol. 2017;8:106.","journal-title":"Front Endocrinol"},{"issue":"5","key":"1812_CR32","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S2213-8587(20)30042-5","volume":"8","author":"D Ehrmann","year":"2020","unstructured":"Ehrmann D, Kulzer B, Roos T, Haak T, Al-Khatib M, Hermanns N. Risk factors and prevention strategies for diabetic ketoacidosis in people with established type\u00a01 diabetes. Lancet Diabetes Endocrinol. 2020;8(5):436\u201346.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1812_CR33","volume-title":"Diabetes in America","author":"AM Secrest","year":"2018","unstructured":"Secrest AM, Washington RE, Orchard TJ, et al. Mortality in type\u00a01 diabetes. In: Cowie CC, Casagrande SS, Menke A, et al., editors. Diabetes in America. 3rd ed. Bethesda: National Institute of Diabetes and Digestive and Kidney Diseases (US); 2018.","edition":"3"},{"key":"1812_CR34","doi-asserted-by":"publisher","DOI":"10.2337\/db2020-31","volume-title":"The role of blood glucose monitoring in diabetes management","author":"RS Weinstock","year":"2020","unstructured":"Weinstock RS, Aleppo G, Bailey TS, et al. The role of blood glucose monitoring in diabetes management. Arlington: American Diabetes Association; 2020."},{"issue":"11","key":"1812_CR35","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.7326\/M22-2477","volume":"175","author":"A Gaffney","year":"2022","unstructured":"Gaffney A, Himmelstein DU, Woolhandler S. Prevalence and correlates of patient rationing of insulin in the United States: a national survey. Ann Intern Med. 2022;175(11):1623\u20136.","journal-title":"Ann Intern Med"},{"key":"1812_CR36","unstructured":"Australian Government Department of Health. National Diabetes Services Scheme. Canberra: Department of Health; 2023."},{"issue":"7","key":"1812_CR37","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/pedi.13101","volume":"21","author":"TJ Songer","year":"2020","unstructured":"Songer TJ, Haymond MW, Glazner JE, et al. Healthcare and associated costs related to type\u00a01 diabetes. Pediatr Diabetes. 2020;21(7):1132\u201341.","journal-title":"Pediatr Diabetes"},{"issue":"11","key":"1812_CR38","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.2337\/dc12-2643","volume":"36","author":"JH Simmons","year":"2013","unstructured":"Simmons JH, Chen V, Miller KM, et al. Differences in the management of type\u00a01 diabetes among adults under excellent control compared with those under poor control in the T1D Exchange Clinic Registry. Diabetes Care. 2013;36(11):3573\u20137.","journal-title":"Diabetes Care"},{"issue":"11","key":"1812_CR39","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1111\/dme.12792","volume":"32","author":"S Roze","year":"2015","unstructured":"Roze S, Smith-Palmer J, Valentine W, et al. Cost-effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in type\u00a01 diabetes: a systematic review. Diabet Med. 2015;32(11):1415\u201324.","journal-title":"Diabet Med"},{"issue":"1","key":"1812_CR40","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/01.CCM.0000249825.18677.D2","volume":"35","author":"SV Bull","year":"2007","unstructured":"Bull SV, Douglas IS, Foster M, Albert RK. Mandatory protocol for treating adult patients with diabetic ketoacidosis decreases intensive care unit and hospital lengths of stay: results of a nonrandomized trial. Crit Care Med. 2007;35(1):41\u20136.","journal-title":"Crit Care Med"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-025-01812-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-025-01812-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-025-01812-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T16:03:52Z","timestamp":1763481832000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-025-01812-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,1]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1812"],"URL":"https:\/\/doi.org\/10.1007\/s13300-025-01812-w","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,1]]},"assertion":[{"value":"29 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors (Fayez AlShamsi, Ketan K. Dhatariya, Meira Sulaiman Aldhanhani, Naser Salem Alshkeili, Mohammed Hareb M. Alsaadi, Rashid Hamad Almansoori, and Adnan Agha) declare that they have no conflicts of interest except for Ketan K. Dhatariya as below. Ketan Dhatariya is an Editorial Board member of\n                      Diabetes Therapy\n                      . Ketan Dhatariya was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Ethical approval was obtained from Tawam Human Research Ethics Committee, approval number MF2058-2023-916 with a waiver of informed consent due to the retrospective design and use of de-identified data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}